Chambers Rebecca
SEC insider (Form 3/4/5 filer). CIK 0001823563. Chief Financial Officer at VERACYTE, INC. (VCYT) and 2 other issuers. 31 reported Form 4/5 transactions since Sep 2024; latest on Sep 4, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Chambers Rebecca has filed insider reports for
- VERACYTE, INC. (VCYT): Officer, Chief Financial Officer
- Alamar Biosciences, Inc. (ALMR): Director
- Inari Medical, Inc. (NARI): Director
Chambers Rebecca
CIK: 0001823563
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Sep 4, 2026VCYT
VERACYTE, INC.
SaleDirect1.2K shares at avg. $43.71$51K - Sep 4, 2026VCYT
VERACYTE, INC.
SaleDirect2.5K shares at avg. $42.81$106K - Sep 2, 2026VCYT
VERACYTE, INC.
Tax PaymentDirect3.6K shares at avg. $44.88$162K - Jun 4, 2026VCYT
VERACYTE, INC.
SaleDirect2K shares at avg. $50.09$98K - Jun 4, 2026VCYT
VERACYTE, INC.
SaleDirect1.6K shares at avg. $49.28$79K - Jun 2, 2026VCYT
VERACYTE, INC.
Tax PaymentDirect3.7K shares at avg. $47.80$177K - Apr 20, 2026ALMR
Alamar Biosciences, Inc.
OtherDirectStock Option (Right to Buy)
140.6K shares- - Apr 20, 2026ALMR
Alamar Biosciences, Inc.
OtherDirectStock Option (Right to Buy)
140.6K shares- - Mar 6, 2026VCYT
VERACYTE, INC.
AwardDirect13.2K shares- - Mar 6, 2026VCYT
VERACYTE, INC.
AwardDirect36.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 |  VCYT VERACYTE, INC. | Sale | 1,175 | $43.71 | $51,364 | Direct |
| Sep 4, 2026 | VCYT VERACYTE, INC. | Sale | 2,477 | $42.81 | $106,030 | Direct |
| Sep 2, 2026 | VCYT VERACYTE, INC. | Tax Payment | 3,603 | $44.88 | $161,703 | Direct |
| Jun 4, 2026 | VCYT VERACYTE, INC. | Sale | 1,961 | $50.09 | $98,229 | Direct |
| Jun 4, 2026 | VCYT VERACYTE, INC. | Sale | 1,600 | $49.28 | $78,854 | Direct |
| Jun 2, 2026 | VCYT VERACYTE, INC. | Tax Payment | 3,693 | $47.80 | $176,525 | Direct |
| Apr 20, 2026 |  ALMR Alamar Biosciences, Inc. | Other Stock Option (Right to Buy) | 140,612 | - | - | Direct |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | Other Stock Option (Right to Buy) | 140,612 | - | - | Direct |
| Mar 6, 2026 | VCYT VERACYTE, INC. | Award | 13,157 | - | $0 | Direct |
| Mar 6, 2026 | VCYT VERACYTE, INC. | Award | 36,181 | - | $0 | Direct |
1-10 of 31 transactions